Literature DB >> 29540547

Kainate Receptors Inhibit Glutamate Release Via Mobilization of Endocannabinoids in Striatal Direct Pathway Spiny Projection Neurons.

John J Marshall1, Jian Xu1, Anis Contractor2,3.   

Abstract

Kainate receptors are members of the glutamate receptor family that function by both generating ionotropic currents through an integral ion channel pore and coupling to downstream metabotropic signaling pathways. They are highly expressed in the striatum, yet their roles in regulating striatal synapses are not known. Using mice of both sexes, we demonstrate that GluK2-containing kainate receptors expressed in direct pathway spiny projection neurons (dSPNs) inhibit glutamate release at corticostriatal synapses in the dorsolateral striatum. This inhibition requires postsynaptic kainate-receptor-mediated mobilization of a retrograde endocannabinoid (eCB) signal and activation of presynaptic CB1 receptors. This pathway can be activated during repetitive 25 Hz trains of synaptic stimulation, causing short-term depression of corticostriatal synapses. This is the first study to demonstrate a role for kainate receptors in regulating eCB-mediated plasticity at the corticostriatal synapse and demonstrates an important role for these receptors in regulating basal ganglia circuits.SIGNIFICANCE STATEMENT The GRIK2 gene, encoding the GluK2 subunit of the kainate receptor, has been linked to several neuropsychiatric and neurodevelopmental disorders including obsessive compulsive disorder (OCD). Perseverative behaviors associated with OCD are known to result from pathophysiological changes in the striatum and kainate receptor knock-out mice have striatal-dependent phenotypes. However, the role of kainate receptors in striatal synapses is not known. We demonstrate that GluK2-containing kainate receptors regulate corticostriatal synapses by mobilizing endocannabinoids from direct pathway spiny projection neurons. Synaptic activation of GluK2 receptors during trains of synaptic input causes short-term synaptic depression, demonstrating a novel role for these receptors in regulating striatal circuits.
Copyright © 2018 the authors 0270-6474/18/383901-10$15.00/0.

Entities:  

Keywords:  endocannabinoid; kainate receptor; short-term plasticity; spiny projection neuron; striatum

Mesh:

Substances:

Year:  2018        PMID: 29540547      PMCID: PMC5907053          DOI: 10.1523/JNEUROSCI.1788-17.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  71 in total

1.  Kainate receptors are involved in short- and long-term plasticity at mossy fiber synapses in the hippocampus.

Authors:  A Contractor; G Swanson; S F Heinemann
Journal:  Neuron       Date:  2001-01       Impact factor: 17.173

Review 2.  Endocannabinoid liberation from neurons in transsynaptic signaling.

Authors:  David M Lovinger
Journal:  J Mol Neurosci       Date:  2007-09       Impact factor: 3.444

3.  Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice.

Authors:  C Mulle; A Sailer; I Pérez-Otaño; H Dickinson-Anson; P E Castillo; I Bureau; C Maron; F H Gage; J R Mann; B Bettler; S F Heinemann
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

4.  Spontaneous subthreshold membrane potential fluctuations and action potential variability of rat corticostriatal and striatal neurons in vivo.

Authors:  E A Stern; A E Kincaid; C J Wilson
Journal:  J Neurophysiol       Date:  1997-04       Impact factor: 2.714

5.  Postsynaptic endocannabinoid release is critical to long-term depression in the striatum.

Authors:  G L Gerdeman; J Ronesi; D M Lovinger
Journal:  Nat Neurosci       Date:  2002-05       Impact factor: 24.884

6.  Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania.

Authors:  G Shaltiel; S Maeng; O Malkesman; B Pearson; R J Schloesser; T Tragon; M Rogawski; M Gasior; D Luckenbaugh; G Chen; H K Manji
Journal:  Mol Psychiatry       Date:  2008-03-11       Impact factor: 15.992

7.  Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder.

Authors:  Richard Delorme; Marie-Odile Krebs; Nadia Chabane; Isabelle Roy; Bruno Millet; Marie Christine Mouren-Simeoni; Wolfgang Maier; Thomas Bourgeron; Marion Leboyer
Journal:  Neuroreport       Date:  2004-03-22       Impact factor: 1.837

Review 8.  Striatal circuits, habits, and implications for obsessive-compulsive disorder.

Authors:  Eric Burguière; Patricia Monteiro; Luc Mallet; Guoping Feng; Ann M Graybiel
Journal:  Curr Opin Neurobiol       Date:  2014-09-19       Impact factor: 6.627

9.  A common variant in the 3'UTR of the GRIK4 glutamate receptor gene affects transcript abundance and protects against bipolar disorder.

Authors:  B S Pickard; H M Knight; R S Hamilton; D C Soares; R Walker; J K F Boyd; J Machell; A Maclean; K A McGhee; A Condie; D J Porteous; D St Clair; I Davis; D H R Blackwood; W J Muir
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-29       Impact factor: 11.205

10.  Genome-wide association study of obsessive-compulsive disorder.

Authors:  S E Stewart; D Yu; J M Scharf; B M Neale; J A Fagerness; C A Mathews; P D Arnold; P D Evans; E R Gamazon; L K Davis; L Osiecki; L McGrath; S Haddad; J Crane; D Hezel; C Illman; C Mayerfeld; A Konkashbaev; C Liu; A Pluzhnikov; A Tikhomirov; C K Edlund; S L Rauch; R Moessner; P Falkai; W Maier; S Ruhrmann; H-J Grabe; L Lennertz; M Wagner; L Bellodi; M C Cavallini; M A Richter; E H Cook; J L Kennedy; D Rosenberg; D J Stein; S M J Hemmings; C Lochner; A Azzam; D A Chavira; E Fournier; H Garrido; B Sheppard; P Umaña; D L Murphy; J R Wendland; J Veenstra-VanderWeele; D Denys; R Blom; D Deforce; F Van Nieuwerburgh; H G M Westenberg; S Walitza; K Egberts; T Renner; E C Miguel; C Cappi; A G Hounie; M Conceição do Rosário; A S Sampaio; H Vallada; H Nicolini; N Lanzagorta; B Camarena; R Delorme; M Leboyer; C N Pato; M T Pato; E Voyiaziakis; P Heutink; D C Cath; D Posthuma; J H Smit; J Samuels; O J Bienvenu; B Cullen; A J Fyer; M A Grados; B D Greenberg; J T McCracken; M A Riddle; Y Wang; V Coric; J F Leckman; M Bloch; C Pittenger; V Eapen; D W Black; R A Ophoff; E Strengman; D Cusi; M Turiel; F Frau; F Macciardi; J R Gibbs; M R Cookson; A Singleton; J Hardy; A T Crenshaw; M A Parkin; D B Mirel; D V Conti; S Purcell; G Nestadt; G L Hanna; M A Jenike; J A Knowles; N Cox; D L Pauls
Journal:  Mol Psychiatry       Date:  2012-08-14       Impact factor: 15.992

View more
  4 in total

1.  Conditional Knock-out of mGluR5 from Astrocytes during Epilepsy Development Impairs High-Frequency Glutamate Uptake.

Authors:  Anthony D Umpierre; Peter J West; John A White; Karen S Wilcox
Journal:  J Neurosci       Date:  2018-11-30       Impact factor: 6.167

Review 2.  Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment.

Authors:  Andrew Scheyer; Farhana Yasmin; Saptarnab Naskar; Sachin Patel
Journal:  Neuropsychopharmacology       Date:  2022-09-13       Impact factor: 8.294

Review 3.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

4.  Kainate receptors regulate the functional properties of young adult-born dentate granule cells.

Authors:  Yiwen Zhu; John N Armstrong; Anis Contractor
Journal:  Cell Rep       Date:  2021-09-21       Impact factor: 9.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.